News Guangdong

Guangdong inks 905 mln RMB deals with foreign investors

HSBC to invest an additional 3 billion RMB plus in China by 2025

Sanofi to introduce 25 innovative drugs and indications to Chinese mainland by 2025

Guangdong announced to build 10 provincial-level key TCM research laboratories for infectious diseases prevention and treatment this year.
“Guangdong enjoys a very sound manufacturing base, good business environment and supporting services. We will increase our investment and develop the Quantum Hi-tech (Guangdong) Biological Co., Ltd. in Jiangmen as our global R&D and manufacturing base for prebiotics,” Michelle Liu, Vice President of Corporate Affairs, Asia Pacific, Tate & Lyle, told GDToday while participating in the Special Event of Presenting Guangdong Province of “Invest in China Year” held on March 29.